Philippe Wolgen
Chief Executive Officer bei CLINUVEL PHARMACEUTICALS LIMITED
Vermögen: 32 Mio $ am 31.03.2024
Profil
Philippe Jacques Wolgen is currently the Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd.
and also serves as a Director at Clinuvel (UK) Ltd.
He holds an MBA from The Trustees of Columbia University in The City of New York and London Business School, and a doctorate from the University of Utrecht.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.11.2023 | 3 425 222 ( 6,83% ) | 32 Mio $ | 31.03.2024 |
Aktive Positionen von Philippe Wolgen
| Unternehmen | Position | Beginn |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 01.11.2005 |
Clinuvel (UK) Ltd.
 Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Director/Board Member | 25.11.2005 |
Ausbildung von Philippe Wolgen
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
| London Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Health Technology |
